title: Crizotinib-induced acute interstitial lung disease in a patient with EML4-ALK positive non-small cell lung cancer and chronic interstitial pneumonia.
authors.affiliation: Department of Respiratory Medicine and Allergy, Tosei General Hospital , Seto, Aichi , Japan.
authors.forename: Naohiro
authors.initials: N
authors.lastname: Watanabe
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Nakahara
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Taniguchi
authors.forename: Tomoki
authors.initials: T
authors.lastname: Kimura
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Kondoh
authors.forename: Kensuke
authors.initials: K
authors.lastname: Kataoka
authors.forename: Koji
authors.initials: K
authors.lastname: Sakamoto
mesh_terms: D000208:Acute Disease; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D002908:Chronic Disease; D000077547:Crizotinib; D017809:Fatal Outcome; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000235:genetics / Q000378:metabolism*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011720:Pyrazoles / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*
chemical_list: C522504:EML4-ALK fusion protein, human; D015514:Oncogene Proteins, Fusion; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib